Vertex may have to pay more than $65 for Alpine Immune stock ($ALPN)

Alpine Immune Sciences Inc (NASDAQ: ALPN) is up 35% on Thursday after Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) said it will acquire the biotechnology company for 65 per share.Are you looking for signals & alerts from pro-traders? Sign-up to Invezz Signals™ for FREE. Takes 2 mins.Is Alpine Immune stock fairly valued at 65? Copy link to section But shareholders of the $5.0 billion company based out of Seattle, Washington may end up getting even more than$65 per share considering Halper Sadeh LLC ...